AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.

Bibliographic Details
Title: AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis.
Authors: Qianshan Ding, Jian Kang, Jinfen Dai, Meng Tang, Qi Wang, Haotian Zhang, Wenyi Guo, Rongze Sun, Honggang Yu
Source: Journal of Clinical Pathology; Mar2016, Vol. 69 Issue 3, p215-220, 6p, 1 Chart, 4 Graphs
Subject Terms: ALANINE aminotransferase, LIVER cancer, IMMUNOHISTOCHEMISTRY, KAPLAN-Meier estimator, SMALL interfering RNA, GENE expression
Abstract: Aims To clarify the clinical implications and functional role of the alanine-glyoxylate aminotransferase 2-like 1 (AGXT2L1) gene in hepatocellular carcinoma (HCC). Methods and results We confirmed that AGXT2L1 was down-regulated in liver cancer samples by immunohistochemical (IHC) staining. We also demonstrated that this down-regulation was associated with several clinicopathological features such as alpha fetoprotein (AFP) serum level and T stage. Furthermore, we showed with Kaplan-Meier analysis that expression of AGXT2L1 in tumour samples was significantly correlated with patient prognosis. The bioinformatic tool indicated that AGXT2L1 plays a role in the lipid metabolic process of HCC tissue, while siRNA silenced the expression of AGXT2L1 in HCC 97H and LM3 cells, confirming that down-regulation of AGXT2L1 promotes the lipogenesis of cancer cells. Conclusions For the first time, we have shown that AGXT2L1 is down-regulated in HCC and its low expression indicates a poor prognosis. Our findings also demonstrated that AGXT2L1 is a crucial gene in the abnormal lipogenesis of HCC tissue. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Clinical Pathology is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:00219746
DOI:10.1136/jclinpath-2015-203042
Published in:Journal of Clinical Pathology
Language:English